Task: Answer the multiple-choice question.
Query: Which drug exhibits a 13.230% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCC1(c2ccccc2)NC(=O)N(CC(=O)N(C)CC(=O)Nc2cccc(OC)c2)C1=O
b: O=C(Nc1ccc(F)c(S(=O)(=O)N2CCOCC2)c1)C1CCCCC1
Answer: a. CCC1(c2ccccc2)NC(=O)N(CC(=O)N(C)CC(=O)Nc2cccc(OC)c2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1(c2ccccc2)NC(=O)N(CC(=O)N(C)CC(=O)Nc2cccc(OC)c2)C1=O
CCC1(c2ccccc2)NC(=O)N(CC(=O)N(C)CC(=O)Nc2cccc(OC)c2)C1=O
2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)-N-[2-(3-methoxyanilino)-2-oxoethyl]-N-methylacetamide